Missed Opportunities: Substance Use Hotline Operator Uncertainty of State Buprenorphine Prescribing via Telemedicine.

J Addict Med

From the Department of Community Health Sciences, Boston University School of Public Health, Boston, MA (DFH, ERA); Department of Health Policy and Management, Rollins School of Public Health, Emory University, Atlanta, GA (CRY); Division of General Internal Medicine at Zuckerberg San Francisco General Hospital, Department of Medicine, University of California San Francisco, San Francisco, CA (LWS); School of Law, Northeastern University, Boston, MA (LB); Department of Health Sciences, Bouve College of Health Sciences, Northeastern University, Boston, MA (LB); and Health in Justice Action Lab, Northeastern University, Boston, MA (LB).

Published: February 2024

Objectives: We examined substance use hotline operator certainty of each US state and Washington, DC's endorsement of buprenorphine (initiation and continuation) prescribing via telemedicine.

Methods: Between March and May 2021, we called hotlines in 50 US states and Washington, DC, requesting information on whether practitioners in that state could initiate or continue buprenorphine treatment for opioid use disorder (OUD) via telephone or video conference. We compared operator responses to state implementation of buprenorphine telemedicine initiation. This study was designated as not human subjects research by the Boston University Institutional Review Board.

Results: We spoke with operators in 47 states and Washington, DC. Operators could not be reached in Alaska, California, and Montana. Most operators were uncertain (don't know, probably yes, probably no) whether the state permitted buprenorphine initiation (81%, n = 39) or continuation (83%, n = 40) via telemedicine. Practitioners could initiate buprenorphine prescribing via telemedicine in 7 states (100%) where operators were certain practitioners could initiate buprenorphine, 1 state (100%) where the operator was certain practitioners could not, and 6 states (86%) where operators indicated practitioners probably could not.

Conclusions: Most US states and Washington, DC, expanded the role of telemedicine in OUD treatment. However, most operators expressed uncertainty and sometimes communicated inaccurate information regarding whether practitioners could initiate buprenorphine treatment via telemedicine. There is an urgent need for policy mandates institutionalizing the role of telemedicine, and of buprenorphine specifically, in OUD treatment and for resources to train and support substance use hotline operators in this evolving policy environment.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10873116PMC
http://dx.doi.org/10.1097/ADM.0000000000001255DOI Listing

Publication Analysis

Top Keywords

substance hotline
12
states washington
12
practitioners initiate
12
initiate buprenorphine
12
buprenorphine
9
hotline operator
8
buprenorphine prescribing
8
prescribing telemedicine
8
buprenorphine initiation
8
buprenorphine treatment
8

Similar Publications

Introduction: The overdose epidemic continues to be one of the largest public health crises in Canada. Various harm reduction supports have been implemented to curb this epidemic; however, they remain concentrated within urban settings. To address this limitation, overdose response hotlines and applications (ORHA) are novel, technologybased harm reduction services that may reduce drug-related mortality for people who use substances (PWUS) living in rural communities through virtual supervised consumption.

View Article and Find Full Text PDF

Are virtual harm reduction interventions right for everyone?: A qualitative study of the appropriateness of overdose response hotlines and applications for different subgroups of people who use substances.

J Subst Use Addict Treat

January 2025

Department of Medicine, Faculty of Medicine & Dentistry, University of Alberta, 2J2.00 Walter C Mackenzie Health Sciences Centre, 8440 112 St. NW, Edmonton, AB T6G 2R7, Canada; Department of Internal Medicine, Faculty of Medicine & Dentistry, University of Alberta, 2J2.00 Walter C Mackenzie Health Sciences Centre, 8440 112 St. NW, Edmonton, AB T6G 2R7, Canada. Electronic address:

Introduction: Overdose response hotlines and apps are novel virtual harm reduction technologies that allow remote monitoring of individuals while they use substances (especially if they use alone) through electronic means. The authors explored partner perspectives to determine which groups of people who use substances (PWUS) these services would be most appropriate for, with the aim of better informing service providers on how to target their use to maximize benefit for clients.

Methods: The study conducted 64 semi-structured interviews with participants from a variety of backgrounds (individuals with lived or living experience of substance use, lay persons, health care providers, harm reduction workers, and operational experts).

View Article and Find Full Text PDF

Background: Morbidity and mortality related to substance use have risen to catastrophic levels in North America, and treatment services are often difficult to access. In response, the province of British Columbia (BC), Canada, launched a province-wide addiction medicine support phone line that offers clinicians immediate access to phone consultation with an addictions medicine expert. The service operates 24/7 is accessible to any clinician in the province seeking assistance with an addiction-related question.

View Article and Find Full Text PDF

Objective: The enabling behaviors of family members of psychoactive substance users can be crucial in maintaining addiction. There are no psychometrically evaluated instruments to measure the frequency of the enabling behaviors of family members of psychoactive substance users. Therefore, this study aimed to assess the internal consistency and factor structure of the Behavioral Enabling Scale.

View Article and Find Full Text PDF
Article Synopsis
  • Significant inequalities in smoking rates exist, particularly among low-socio-economic status individuals, prompting a trial to compare tailored text-message quit support with standard Quitline services in Australia.
  • This randomized trial involves 1,246 daily smokers from low-SES backgrounds in the Sydney area, examining the effectiveness of 12 months of text-message support versus telephone support for quitting.
  • The primary outcome focuses on verifying 6-month continuous abstinence rates, assessing if the text-message program is at least as effective as the Quitline service by a small margin, along with evaluating cost-effectiveness.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!